A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma.

A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma.
复制标题

区分肺鳞癌和腺癌的预测模型

DOI:
10.18632/oncotarget.17038
复制
发表时间:
2017-08-01
期刊:
影响因子:
--
通讯作者:
Jiang F
Jiang F
中科院分区:
其他
文献类型:
--
作者:
Li H;Jiang Z;Leng Q;Bai F;Wang J;Ding X;Li Y;Zhang X;Fang H;Yfantis HG;Xing L;Jiang F

文献摘要

参考文献

被引文献

相似文献

非小细胞肺癌(NSCLC)的鳞状细胞癌(SCC)和腺癌(AC)的准确分类可以导致肺癌的个性化治疗。我们的目的是建立一个基于mirna的预测模型,用于在手术切除组织和支气管肺泡灌洗(BAL)样本中区分SCC和AC。采用逆转录聚合酶链反应(RT-PCR)技术检测了128个快速冷冻手术肺肿瘤标本中7个组织学亚型相关mirna的表达水平,以建立一个最佳的mirna小组,用于急性区分SCC和AC。这些生物标志物在112个FFPE肺肿瘤组织的独立队列中得到验证。建立了两种mirna (miRs-205-5p和944)的预测模型,该模型用于冷冻组织中SCC与AC的鉴别,曲线下面积(AUC)为0.988,灵敏度为96.55%,特异性为96.43%;用于FFPE标本的鉴别,AUC为0.997,灵敏度为96.43%,特异性为96.43%。预测模型的诊断性能在BAL标本中可重复验证,用于区分SCC和AC,与细胞学相比准确率更高(95.69比68.10%,P < 0.05)。该预测模型对于准确区分外科肺肿瘤组织和液体细胞学标本中的SCC和AC可能具有临床价值。
Accurate classification of squamous cell carcinoma (SCC) from adenocarcinoma (AC) of non–small cell lung cancer (NSCLC) can lead to personalized treatments of lung cancer. We aimed to develop a miRNA-based prediction model for differentiating SCC from AC in surgical resected tissues and bronchoalveolar lavage (BAL) samples. Expression levels of seven histological subtype-associated miRNAs were determined in 128 snap-frozen surgical lung tumor specimens by using reverse transcription-polymerase chain reaction (RT-PCR) to develop an optimal panel of miRNAs for acutely distinguishing SCC from AC. The biomarkers were validated in an independent cohort of 112 FFPE lung tumor tissues, and a cohort of 127 BAL specimens by using droplet digital PCR for differentiating SCC from AC. A prediction model with two miRNAs (miRs-205-5p and 944) was developed that had 0.988 area under the curve (AUC) with 96.55% sensitivity and 96.43% specificity for differentiating SCC from AC in frozen tissues, and 0.997 AUC with 96.43% sensitivity and 96.43% specificity in FFPE specimens. The diagnostic performance of the prediction model was reproducibly validated in BAL specimens for distinguishing SCC from AC with a higher accuracy compared with cytology (95.69 vs. 68.10%; P < 0.05). The prediction model might have a clinical value for accurately discriminating SCC from AC in both surgical lung tumor tissues and liquid cytological specimens.
DOI: 10.1634/theoncologist.2015-0507
发表时间: 2016-05
期刊: The oncologist
影响因子: --
作者:
Kazandjian D;Suzman DL;Blumenthal G;Mushti S;He K;Libeg M;Keegan P;Pazdur R
通讯作者: Pazdur R
DOI: 10.4137/bic.s37333
发表时间: 2016
期刊: Biomarkers in cancer
影响因子: --
作者:
Ma J;Li N;Lin Y;Gupta C;Jiang F
通讯作者: Jiang F
DOI: 10.1002/ijc.29169
发表时间: 2015-03-15
影响因子: 6.4
作者:
Gao, Lu;Ma, Jie;Jiang, Feng
通讯作者: Jiang, Feng
DOI: 10.1186/2001-1326-2-15
发表时间: 2013-09-22
影响因子: 10.6
作者:
Anjuman N;Li N;Guarnera M;Stass SA;Jiang F
通讯作者: Jiang F
DOI: 10.1038/labinvest.2015.88
发表时间: 2015-10
期刊: Laboratory investigation; a journal of technical methods and pathology
影响因子: --
作者:
Ma J;Lin Y;Zhan M;Mann DL;Stass SA;Jiang F
通讯作者: Jiang F